Mats Jerkeman
Mats Jerkeman publishes mostly in Pathology and Forensic Medicine, Oncology and Genetics, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Viral-associated cancers and disorders.
- World rank
- #450,293 of 7,710,434 ranked researchers
- Rank in Sweden
- #5,433 of 71,437
- Works
- 392
- Citations
- 11k
- Citations per work
- 28.6
What does Mats Jerkeman research?
Mats Jerkeman's work is mostly in Medicine (69%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences27068.9%
- Medicine27068.9%
- Everything else10326.3%
- Life Sciences194.8%
- 1Pathology and Forensic Medicine31% of their works
- 2Oncology16% of their works
- 3Genetics11% of their works
- 4Neurology6% of their works
- 5Pulmonary and Respiratory Medicine5% of their works
- 6Immunology5% of their works
Research topics
Which keywords describe Mats Jerkeman's research?
The keywords of their largest research topics: Rituximab, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations and Chemotherapy.
- Soft Tissue Sarcoma
- Targeted Therapy
- Mycosis Fungoides
- Chimeric Antigen Receptor
- Prognostic Scoring System
- Kaposi's Sarcoma
- Chemotherapy
- Chronic Lymphocytic Leukemia
- Molecular Profiling
- Lymphoma
- Rituximab
- Classification
- Prognostic Factors
- Genomic Aberrations
- Epstein-Barr Virus
- Primary CNS Lymphoma
- CAR T Cells
- Cutaneous Lymphomas
- EGFR Mutations
- Osteosarcoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Rituximab4302 topics
- Lymphoma3732 topics
- Classification3261 topic
- Molecular Profiling3261 topic
- Prognostic Factors1613 topics
- Chronic Lymphocytic Leukemia1041 topic
- Genomic Aberrations1041 topic
- Chemotherapy862 topics
- Epstein-Barr Virus671 topic
- Kaposi's Sarcoma671 topic
- Primary CNS Lymphoma641 topic
- Prognostic Scoring System641 topic
- CAR T Cells471 topic
- Chimeric Antigen Receptor471 topic
- Cutaneous Lymphomas351 topic
- Mycosis Fungoides351 topic
- EGFR Mutations301 topic
- Targeted Therapy301 topic
- Osteosarcoma221 topic
- Soft Tissue Sarcoma221 topic
Where does Mats Jerkeman work?
Mats Jerkeman's main affiliation in the publication record is Lund University, Sweden.
How many publications and citations does Mats Jerkeman have?
OpenAlex counts 392 works and 11,199 citations for Mats Jerkeman, an h-index of 53, ranking #450,293 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mats Jerkeman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.